Literature DB >> 21680221

Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI.

Cécile Gaujoux-Viala1, Gaël Mouterde, Athan Baillet, Pascal Claudepierre, Bruno Fautrel, Xavier Le Loët, Jean-Francis Maillefert.   

Abstract

OBJECTIVES: To evaluate and compare four composite indices for assessing the activity of rheumatoid arthritis (RA).
METHODS: We conducted a systematic literature review by searching Medline via PubMed and Embase and Cochrane databases for articles published up to March 2009. We selected studies that directly compared at least two of the four composite indices. The DAS (Disease Activity Score), DAS28, Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) were evaluated in terms of reproducibility, construct validity, discriminative performance, and sensitivity to change.
RESULTS: We included 61 articles. The only study that directly compared the intraobserver reproducibility of the DAS28, SDAI, and CDAI found comparable intraclass correlation coefficients ranging from 0.85 to 0.89. Concordance among indices was good (kappa values of ∼0.7), except between the DAS28 and the other indices in definition of remission (kappa 0.48-0.63). The indices had good construct validity by their similar fair-to-good correlations with the Health Assessment Questionnaire (HAQ) score and structural damage. Discriminative performance was comparable and satisfactory for treatment changes or remission according to the American College of Rheumatology (ACR). Two studies evaluated the sensitivity to change of the SDAI and CDAI; both indices detected a difference between responders and non-responders according to ACR definitions.
CONCLUSION: The DAS, DAS28, SDAI, and CDAI are valid tools for evaluating the activity of RA. The DAS28 is less conservative in defining remission than are the other three indices. Longitudinal studies of individual patients are needed to confirm these results. Copyright Â
© 2011 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21680221     DOI: 10.1016/j.jbspin.2011.04.008

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  35 in total

1.  SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis.

Authors:  Emilce Edith Schneeberger; Natalia Zamora; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2016-06-29       Impact factor: 2.980

2.  HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis.

Authors:  Kyung-Eun Lee; Sung-Eun Choi; Haimuzi Xu; Ji-Hyoun Kang; Dong-Jin Park; Shin-Seok Lee
Journal:  Rheumatol Int       Date:  2017-09-27       Impact factor: 2.631

Review 3.  [Musculoskeletal-related chest pain].

Authors:  C Sturm; T Witte
Journal:  Internist (Berl)       Date:  2017-01       Impact factor: 0.743

4.  Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab.

Authors:  Toshikatsu Kaburaki; Kenichi Namba; Koh-hei Sonoda; Takeshi Kezuka; Hiroshi Keino; Takako Fukuhara; Koju Kamoi; Kei Nakai; Nobuhisa Mizuki; Nobuyuki Ohguro
Journal:  Jpn J Ophthalmol       Date:  2014-01-31       Impact factor: 2.447

5.  Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study.

Authors:  M Eissa; A El Shafey; M Hammad
Journal:  Clin Rheumatol       Date:  2017-05-22       Impact factor: 2.980

6.  Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study.

Authors:  Irazú Contreras-Yáñez; Guillermo Guaracha-Basáñez; Virginia Pascual-Ramos
Journal:  Rheumatol Int       Date:  2019-10-12       Impact factor: 2.631

7.  The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis.

Authors:  Emmanuel Ruiz-Medrano; Hector Fabricio Espinosa-Ortega; Cesar Alejandro Arce-Salinas
Journal:  Clin Rheumatol       Date:  2019-05-10       Impact factor: 2.980

8.  Utility of pulmonary ultrasound to identify interstitial lung disease in patients with rheumatoid arthritis.

Authors:  Natalia Mena-Vázquez; Francisco Gabriel Jimenez-Núñez; Francisco Javier Godoy-Navarrete; Sara Manrique-Arija; María Carmen Aguilar-Hurtado; Carmen María Romero-Barco; Inmaculada Ureña-Garnica; F Espildora; María Isabel Padin-Martín; Antonio Fernández-Nebro
Journal:  Clin Rheumatol       Date:  2021-02-21       Impact factor: 2.980

9.  Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels.

Authors:  L Semerano; J Biton; L Delavallée; E Duvallet; E Assier; N Bessis; E Bernier; O Dhellin; G Grouard-Vogel; M-C Boissier
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

Review 10.  Assessing rheumatoid arthritis disease activity with ultrasound.

Authors:  Rafael Mendonça da Silva Chakr; José Alexandre Mendonça; Claiton Viegas Brenol; Ricardo Machado Xavier; João Carlos Tavares Brenol
Journal:  Clin Rheumatol       Date:  2013-05-23       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.